Summary by Moomoo AI
On October 11, 2024, two GSK executives reinvested their dividends in company shares through Individual Savings Accounts (ISA). David Redfern, President of Corporate Development, acquired 20 ordinary shares at £14.9650 per share, while Company Secretary Victoria Whyte purchased 17 shares at the same price.The share acquisitions followed the dividend payment to shareholders on October 10, 2024. The transactions were executed on the London Stock Exchange (XLON), demonstrating continued confidence in the company by key executives.
